The Muscular Dystrophies: From Genes to Therapies
Author(s) -
Richard M. Lovering,
Neil C. Porter,
Robert J. Bloch
Publication year - 2005
Publication title -
physical therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.998
H-Index - 150
eISSN - 1538-6724
pISSN - 0031-9023
DOI - 10.1093/ptj/85.12.1372
Subject(s) - muscular dystrophy , medicine , genetic enhancement , muscle disorder , bioinformatics , intensive care medicine , gene , biology , genetics
The genetic basis of many muscular disorders, including many of the more common muscular dystrophies, is now known. Clinically, the recent genetic advances have improved diagnostic capabilities, but they have not yet provided clues about treatment or management. Thanks to better management strategies and therapeutic interventions, however, many patients with a muscular dystrophy are more active and are living longer. Physical therapists, therefore, are more likely to see a patient with a muscular dystrophy, so understanding these muscle disorders and their management is essential. Physical therapy offers the most promise in caring for the majority of patients with these conditions, because it is unlikely that advances in gene therapy will significantly alter their clinical treatment in the near future. This perspective covers some of the basic molecular biological advances together with the clinical manifestations of the muscular dystrophies and the latest approaches to their management.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom